Neonatal severe hyperparathyroidism with inactivating calcium sensing receptor (CaSR) mutation (p.I81K)

Zeynep Donbaloglu1, Merve Gullu2, Suat Tekin2

  • 1Department of Pediatric Endocrinology, Akdeniz University Hospital, Antalya, Türkiye.

Summary

Neonatal severe hyperparathyroidism (NSHPT), caused by CaSR gene mutations, requires early diagnosis. This case shows successful management through bisphosphonates, cinacalcet, and parathyroidectomy, leading to normal development.

Related Concept Videos